
- BioPharm International-03-15-2018
- Volume 2018 eBook
- Issue 1
Outsourcing: Does Focus Pay Off?
Research suggests that working with a single contract partner can reduce development time and improve economics.
Competitive pressures have led to explosive growth in demand for research and development (R&D) outsourcing, especially as smaller biopharma and pharmaceutical companies play a more prominent role in drug development. Pharmaceutical manufacturers, especially small- to mid-sized companies, are discovering that partnering more closely with one diversified contract company can reduce development time and cost.
View other articles in
Article Details
BioPharm International
eBook: Outsourcing Resources 2018
March 2018
Pages: 4–6
Citation
When referring to this article, please cite it as A. Shanley, “Outsourcing: Does Focus Pay Off?," BioPharm International Outsourcing Resources eBook (March 2018).
Articles in this issue
over 7 years ago
Quality Oversight During Sterile Filling Operationsover 7 years ago
Good Quality Agreements Support Compliance with CGMPover 7 years ago
Gaining Analytical Insight in the Development of Biologicsover 7 years ago
Contract Services Investment Updateover 7 years ago
Process Validation in Biologics Developmentover 7 years ago
Bigger is Better in Samsung's Approach to Biomanufacturingover 7 years ago
Choosing an Analytical Partner in Early Drug Developmentover 7 years ago
Avoiding Complete Response LettersNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.